Research Report: Ventricular Assist Devices Market (2020-2024) | Rising Incidence of Heart Failure to boost Market Growth | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the ventricular assist devices market and it is poised to grow by USD 943.27 million during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts

Frequently Asked Questions:

• Based on segmentation by product, which is the leading segment in the market?
  Left and right ventricular assist devices.
  
• What are the major trends in the market?
  Development of next-generation ventricular assist devices with enhanced hemocompatibility and durability.
  
• At what rate is the market projected to grow?
  The market is projected to grow at a CAGR of almost 12% during 2020-2024.
  
• Who are the top players in the market?
  Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, CorWave SA, Fresenius Medical Care AG & Co. KGaA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc. are the top players in the market.
  
• What are the key market drivers and challenges?
  The market is driven by the rising incidence of heart failures. However, high costs associated with ventricular assist devices might hamper the market growth.
  

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, CorWave SA, Fresenius Medical Care AG & Co. KGaA, Jarvik Heart, Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc. are some of the major market participants. The rising incidence of heart failure will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Ventricular Assist Devices Market 2020-2024: Segmentation

Ventricular Assist Devices Market is segmented as below:

• Product
  • Left And Right Ventricular Assist Devices
  • Bi-ventricular Assist Devices
• Geographic Landscape
  • Asia
  • Europe
  • North America
  • ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40227

Ventricular Assist Devices Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The ventricular assist devices market report covers the following areas:

• Ventricular Assist Devices Market Size
• Ventricular Assist Devices Market Trends
• Ventricular Assist Devices Market Industry Analysis

This study identifies the development of next-generation ventricular assist devices with enhanced hemocompatibility and durability as one of the prime reasons driving the Ventricular Assist Devices Market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Ventricular Assist Devices Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist ventricular assist devices market growth during the next five years
• Estimation of the ventricular assist devices market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the ventricular assist devices market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of ventricular assist devices market vendors

Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• Preface
• Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Left and right ventricular assist devices - Market size and forecast 2019-2024
• Bi-ventricular assist devices - Market size and forecast 2019-2024
• Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Technological advances
• Growing number of mergers and acquisitions
• New products in the ventricular assist devices pipeline

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Abiomed Inc.
• Asahi Kasei Corp.
• Berlin Heart GmbH
• CorWave SA
• Fresenius Medical Care AG & Co. KGaA
• Jarvik Heart, Inc.
• LivaNova Plc
• Medtronic Plc
• Mohawk Innovative Technology Inc.

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.